2025-04-012025-08-312025-08-31false04401043BLUEPHARM LIMITED2025-11-1068209falseiso4217:GBPxbrli:pure044010432025-03-31044010432025-08-31044010432025-04-012025-08-31044010432024-03-31044010432025-03-31044010432024-04-012025-03-3104401043bus:SmallEntities2025-04-012025-08-3104401043bus:AuditExempt-NoAccountantsReport2025-04-012025-08-3104401043bus:AbridgedAccounts2025-04-012025-08-3104401043bus:PrivateLimitedCompanyLtd2025-04-012025-08-3104401043core:WithinOneYear2025-08-3104401043core:AfterOneYear2025-08-3104401043core:WithinOneYear2025-03-3104401043core:AfterOneYear2025-03-3104401043core:ShareCapital2025-08-3104401043core:SharePremium2025-08-3104401043core:RevaluationReserve2025-08-3104401043core:OtherReservesSubtotal2025-08-3104401043core:RetainedEarningsAccumulatedLosses2025-08-3104401043core:ShareCapital2025-03-3104401043core:SharePremium2025-03-3104401043core:RevaluationReserve2025-03-3104401043core:OtherReservesSubtotal2025-03-3104401043core:RetainedEarningsAccumulatedLosses2025-03-3104401043core:LandBuildings2025-08-3104401043core:PlantMachinery2025-08-3104401043core:Vehicles2025-08-3104401043core:FurnitureFittings2025-08-3104401043core:OfficeEquipment2025-08-3104401043core:NetGoodwill2025-08-3104401043core:IntangibleAssetsOtherThanGoodwill2025-08-3104401043core:ListedExchangeTraded2025-08-3104401043core:UnlistedNon-exchangeTraded2025-08-3104401043core:LandBuildings2025-03-3104401043core:PlantMachinery2025-03-3104401043core:Vehicles2025-03-3104401043core:FurnitureFittings2025-03-3104401043core:OfficeEquipment2025-03-3104401043core:NetGoodwill2025-03-3104401043core:IntangibleAssetsOtherThanGoodwill2025-03-3104401043core:ListedExchangeTraded2025-03-3104401043core:UnlistedNon-exchangeTraded2025-03-3104401043core:LandBuildings2025-04-012025-08-3104401043core:PlantMachinery2025-04-012025-08-3104401043core:Vehicles2025-04-012025-08-3104401043core:FurnitureFittings2025-04-012025-08-3104401043core:OfficeEquipment2025-04-012025-08-3104401043core:NetGoodwill2025-04-012025-08-3104401043core:IntangibleAssetsOtherThanGoodwill2025-04-012025-08-3104401043core:ListedExchangeTraded2025-04-012025-08-3104401043core:UnlistedNon-exchangeTraded2025-04-012025-08-3104401043core:MoreThanFiveYears2025-04-012025-08-3104401043core:Non-currentFinancialInstruments2025-08-3104401043core:Non-currentFinancialInstruments2025-03-3104401043dpl:CostSales2025-04-012025-08-3104401043dpl:DistributionCosts2025-04-012025-08-3104401043core:LandBuildings2025-04-012025-08-3104401043core:PlantMachinery2025-04-012025-08-3104401043core:Vehicles2025-04-012025-08-3104401043core:FurnitureFittings2025-04-012025-08-3104401043core:OfficeEquipment2025-04-012025-08-3104401043dpl:AdministrativeExpenses2025-04-012025-08-3104401043core:NetGoodwill2025-04-012025-08-3104401043core:IntangibleAssetsOtherThanGoodwill2025-04-012025-08-3104401043dpl:GroupUndertakings2025-04-012025-08-3104401043dpl:ParticipatingInterests2025-04-012025-08-3104401043dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012025-08-3104401043core:ListedExchangeTraded2025-04-012025-08-3104401043dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012025-08-3104401043core:UnlistedNon-exchangeTraded2025-04-012025-08-3104401043dpl:CostSales2024-04-012025-03-3104401043dpl:DistributionCosts2024-04-012025-03-3104401043core:LandBuildings2024-04-012025-03-3104401043core:PlantMachinery2024-04-012025-03-3104401043core:Vehicles2024-04-012025-03-3104401043core:FurnitureFittings2024-04-012025-03-3104401043core:OfficeEquipment2024-04-012025-03-3104401043dpl:AdministrativeExpenses2024-04-012025-03-3104401043core:NetGoodwill2024-04-012025-03-3104401043core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3104401043dpl:GroupUndertakings2024-04-012025-03-3104401043dpl:ParticipatingInterests2024-04-012025-03-3104401043dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3104401043core:ListedExchangeTraded2024-04-012025-03-3104401043dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3104401043core:UnlistedNon-exchangeTraded2024-04-012025-03-3104401043core:NetGoodwill2025-08-3104401043core:IntangibleAssetsOtherThanGoodwill2025-08-3104401043core:LandBuildings2025-08-3104401043core:PlantMachinery2025-08-3104401043core:Vehicles2025-08-3104401043core:FurnitureFittings2025-08-3104401043core:OfficeEquipment2025-08-3104401043core:AfterOneYear2025-08-3104401043core:WithinOneYear2025-08-3104401043core:ListedExchangeTraded2025-08-3104401043core:UnlistedNon-exchangeTraded2025-08-3104401043core:ShareCapital2025-08-3104401043core:SharePremium2025-08-3104401043core:RevaluationReserve2025-08-3104401043core:OtherReservesSubtotal2025-08-3104401043core:RetainedEarningsAccumulatedLosses2025-08-3104401043core:NetGoodwill2025-03-3104401043core:IntangibleAssetsOtherThanGoodwill2025-03-3104401043core:LandBuildings2025-03-3104401043core:PlantMachinery2025-03-3104401043core:Vehicles2025-03-3104401043core:FurnitureFittings2025-03-3104401043core:OfficeEquipment2025-03-3104401043core:AfterOneYear2025-03-3104401043core:WithinOneYear2025-03-3104401043core:ListedExchangeTraded2025-03-3104401043core:UnlistedNon-exchangeTraded2025-03-3104401043core:ShareCapital2025-03-3104401043core:SharePremium2025-03-3104401043core:RevaluationReserve2025-03-3104401043core:OtherReservesSubtotal2025-03-3104401043core:RetainedEarningsAccumulatedLosses2025-03-3104401043core:NetGoodwill2024-03-3104401043core:IntangibleAssetsOtherThanGoodwill2024-03-3104401043core:LandBuildings2024-03-3104401043core:PlantMachinery2024-03-3104401043core:Vehicles2024-03-3104401043core:FurnitureFittings2024-03-3104401043core:OfficeEquipment2024-03-3104401043core:AfterOneYear2024-03-3104401043core:WithinOneYear2024-03-3104401043core:ListedExchangeTraded2024-03-3104401043core:UnlistedNon-exchangeTraded2024-03-3104401043core:ShareCapital2024-03-3104401043core:SharePremium2024-03-3104401043core:RevaluationReserve2024-03-3104401043core:OtherReservesSubtotal2024-03-3104401043core:RetainedEarningsAccumulatedLosses2024-03-3104401043core:AfterOneYear2025-04-012025-08-3104401043core:WithinOneYear2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012025-08-3104401043core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3104401043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3104401043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3104401043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3104401043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3104401043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3104401043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3104401043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3104401043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3104401043core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3104401043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3104401043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3104401043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3104401043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3104401043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3104401043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3104401043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3104401043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3104401043bus:Director12025-04-012025-08-3104401043bus:Director22025-04-012025-08-31

BLUEPHARM LIMITED

Registered Number
04401043
(England and Wales)

Unaudited Financial Statements for the Period ended
31 August 2025

BLUEPHARM LIMITED
Company Information
for the period from 1 April 2025 to 31 August 2025

Directors

SINGH, Fiona Margaret
SINGH, Sarvjit

Company Secretary

SINGH, Fiona Margaret

Registered Address

Brickbarn House
Colchester Road
Halstead
CO9 2EU

Registered Number

04401043 (England and Wales)
BLUEPHARM LIMITED
Balance Sheet as at
31 August 2025

Notes

31 Aug 2025

31 Mar 2025

£

£

£

£

Current assets
Cash at bank and on hand4,908188,924
4,908188,924
Creditors amounts falling due within one year3(4,075)(138,451)
Net current assets (liabilities)83350,473
Total assets less current liabilities83350,473
Net assets83350,473
Capital and reserves
Called up share capital5,0005,000
Profit and loss account(4,167)45,473
Shareholders' funds83350,473
The financial statements were approved and authorised for issue by the Board of Directors on 10 November 2025, and are signed on its behalf by:
SINGH, Fiona Margaret
Director
SINGH, Sarvjit
Director

Registered Company No. 04401043
BLUEPHARM LIMITED
Notes to the Financial Statements
for the period ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20252025
Average number of employees during the year00
3.Creditors: amounts due within one year

2025

2025

££
Taxation and social security1,055971
Other creditors2,480137,480
Accrued liabilities and deferred income540-
Total4,075138,451
Other creditors balance of £2,480 (2025: £137,480) relates to the directors.